Hypertension Trial, Recruiting NCT06545981 Sponsor: Medical University of Vienna Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06545981
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with idiopathic intracranial hypertension (a condition where pressure inside the skull is too high for no clear reason):

  • Adults aged 18 or older
  • People who have recently been diagnosed with idiopathic intracranial hypertension for the first time, or whose condition has returned after a period of improvement
  • Non-smokers
  • People who have signed a consent form agreeing to participate

For healthy volunteers (used as a comparison group, matched by age and sex):

  • Adults aged 18 or older
  • People with normal eye health findings, unless the trial doctor considers any minor difference to be unimportant
  • People with a generally normal medical history, unless the trial doctor considers any minor difference to be unimportant
  • Non-smokers
  • People who have signed a consent form agreeing to participate

Who may not be able to join:

  • People who have donated blood in the three weeks before the study starts
  • People who have had a significant illness in the three weeks before the study starts
  • People who have had an eye inflammation or infection in the past three months
  • People who have a personal or family history of epilepsy
  • People with Type 1 or Type 2 diabetes
  • People with a history of, or known, blood vessel problems in the brain (such as abnormal connections between blood vessels, aneurysms, or blocked or narrowed major arteries)
  • People with a history of, or known, infections inside the skull (such as meningitis)
  • People with a history of, or known, other neurological conditions (such as brain tumours, fluid build-up on the brain, or degenerative brain diseases)
  • People currently taking corticosteroid or immunosuppressant medications (medicines that reduce inflammation or suppress the immune system)
  • Women who are pregnant or breastfeeding
  • Women who could become pregnant and are not using effective contraception (this does not apply to women who have been through menopause, had a hysterectomy, or been surgically sterilised)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +43 1 40400 29880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 May 2024
Est. completion
28 May 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Optic nerve head blood flow

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov